SCHEMBL16554196

SCHEMBL16554196

CC(C)(C)[Si](C)(C)O[C@@H](CO)c1ccc(Cl)c(F)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 10/20 0.38
SLC6A2 P23975 9/20 0.38
SLC6A3 Q01959 9/20 0.38
CYP1A2 P05177 4/20 0.37
CYP3A4 P08684 4/20 0.37
CYP2D6 P10635 4/20 0.37
CYP2C9 P11712 4/20 0.37
CYP2C19 P33261 4/20 0.37
KCNH2 Q12809 2/20 0.36
IDO1 P14902 1/20 0.35
MAPK1 P28482 2/20 0.33
FFAR1 O14842 2/20 0.33
APP P05067 1/20 0.33
CCNA2 P20248 1/20 0.33
CDK2 P24941 1/20 0.33
MAPK3 P27361 1/20 0.33
GPR139 Q6DWJ6 2/20 0.32
S1PR1 P21453 1/20 0.32
S1PR3 Q99500 1/20 0.32
APLNR P35414 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15229246 1.00 SLC6A4 (0.38) SLC6A4SLC6A2SLC6A3CYP1A2CYP3A4
SCHEMBL15229070 0.90 SLC6A2 (0.38) SLC6A4SLC6A2SLC6A3CYP3A4CYP2D6
SCHEMBL15229035 0.90 SLC6A4 (0.37) SLC6A4SLC6A2SLC6A3CYP1A2CYP3A4
SCHEMBL31410509 0.85 SLC6A4 (0.37) SLC6A4SLC6A2SLC6A3CYP1A2CYP3A4
SCHEMBL15229299 0.80 APLNR (0.35) SLC6A4SLC6A2SLC6A3CYP1A2CYP3A4
SCHEMBL15229331 0.80 APLNR (0.35) SLC6A4SLC6A2SLC6A3CYP1A2CYP3A4
SCHEMBL5223462 0.80 AOC3 (0.37) SLC6A4SLC6A2SLC6A3IDO1APLNR
SCHEMBL9063602 0.79 AOC3 (0.43) SLC6A4SLC6A2IDO1
SCHEMBL15229308 0.78 CA2 (0.38) SLC6A4SLC6A2SLC6A3CYP1A2CYP3A4
SCHEMBL6439346 0.78 CA2 (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3041471-A1 COMBINATION OF A MEK INHIBITOR AND AN ERK INHIBITOR FOR USE IN TREATMENT OF HYPERPROLIFERATIVE DISEASES F. Hoffmann-La Roche AG (CH) 2016-07-13 EP disclosed
WO-2015032840-A1 COMBINATION OF A MEK INHIBITOR AND AN ERK INHIBITOR FOR USE IN TREATMENT OF HYPERPROLIFERATIVE DISEASES F. HOFFMANN-LA ROCHE AG (CH) 2015-03-12 WO disclosed